Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2014; 20(7): 1635-1649
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1635
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1635
Table 1 Meta-analyses of adjuvant chemotherapy for resectable gastric cancer
| Ref. | Year | Trials (n) | Patients (n) | OR/HR for death (95%CI) |
| Hermans et al[71] | 1993 | 11 | 2096 | 0.88 (0.78-1.08) |
| Earle et al[57] | 1999 | 13 | 1990 | 0.80 (0.66-0.97) |
| Mari et al[56] | 2000 | 21 | 3658 | 0.82 (0.75-0.89) |
| Panzini et al[58] | 2002 | 17 | 3118 | 0.72 (0.62-0.84) |
| Janunger et al[61] | 2002 | 21 | 3962 | 0.84 (0.74-0.96) |
| Zhao et al[72] | 2008 | 15 | 3212 | 0.90 (0.84-0.96) |
| Liu et al[73] | 2008 | 19 | 4599 | 0.85 (0.80-0.90) |
| GASTRIC group[62] | 2010 | 17 | 3838 | 0.82 (0.76-0.90) |
- Citation: Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, Lieto E, Ciardiello F, De Vita F. Treatment of gastric cancer. World J Gastroenterol 2014; 20(7): 1635-1649
- URL: https://www.wjgnet.com/1007-9327/full/v20/i7/1635.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i7.1635